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During viral replication, both herpesviruses and bacteriophages package viral DNA 
genomes into preformed empty protein shells in a process known as encapsidation.  Although 
this process has been extensively studied in bacteriophages such as SPP1 and 29, it is less 
well understood in herpesviruses.  
Herpesviruses are the causative agents of many human and animal diseases, including 
oral and genital herpes (Herpes simplex viruses 1 and 2), chicken pox and shingles (Varicella-
zoster virus), mononucleosis (Epstein Barr virus), and congenital birth defects 
(Cytomegalovirus).  Currently, treatment for human herpesviral disease is limited in that the 
commercially available drugs all have similar mechanisms of action.  Hence, the possibility of 
producing drug-resistant viral strains exists.  Interestingly, recent research has revealed a large 
degree of homology in both structure and function of protein complexes involved in DNA 
packaging in herpesviruses and bacteriophages. These similarities have proven invaluable in 
directing research focused on elucidating the inner workings of herpesvirus encapsidation 
proteins.  Potential novel drug treatments have been identified (Visalli, R.J., 2004) which are 
putatively known to target the Varicella-zoster virus encapsidation portal protein pORF54.  
Based on homology with other known portal proteins, pORF54 is thought to act as a gateway 
through which DNA is translocated into procapsids. This protein interacts with several other 
proteins which are responsible for binding and cleaving viral DNA, known as the terminase 
complex.  
In the current study, we intend to use recombinant baculoviruses (original wild type: 
Autographa californica), each of which contains a single Varicella-zoster virus encapsidation 
gene, to produce large quantities of purified protein for use in protein interaction experiments 
and functional assays.  We propose that by increasing our understanding of herpesvirus 
encapsidation that additional drug treatments may someday be available for use that are more 
effective and lessen the threat of resistant viral strains. 
